nephrology

Alnylam files its third RNAi drug lumasiran in rare kidney disease

https://pharmaphorum.com/news/alnylam-files-its-third-rnai-drug-lumasiran-in-rare-kidney-disease/

3rd Chronic Kidney Disease Drug Development (CKD3) Summit

https://pharmaphorum.com/events/3rd-chronic-kidney-disease-drug-development-ckd3-summit-2/

3rd Chronic Kidney Disease Drug Development (CKD3) Summit

https://pharmaphorum.com/events/3rd-chronic-kidney-disease-drug-development-ckd3-summit/

Vifor joins forces with Evotec on kidney disease joint venture

https://pharmaphorum.com/news/vifor-joins-forces-with-evotec-on-kidney-disease-joint-venture/

Smartphone screening project for kidney disease launched in the Netherlands

https://pharmaphorum.com/news/smartphone-screening-project-for-kidney-disease-launched-in-the-netherlands/

Otsuka has high hopes for its ‘drug creation engine’ acquisition

https://pharmaphorum.com/news/otsuka-biotech-visterra-hierotope/

EU approves AZ’s potential blockbuster hyperkalaemia drug

https://pharmaphorum.com/news/eu-approves-azs-potential-blockbuster-potassium-drug/

AZ signs kidney drug deal with Ionis for up to $330m

https://pharmaphorum.com/news/az-buys-kidney-disease-drug-from-ionis-for-up-to-330m/

Alexion drug fails in kidney transplant trial

https://pharmaphorum.com/news/alexions-soliris-fails-kidney-transplant-trial/

1 2

Close in 10 seconds

Pharmaphorum.com

Search